Skip to main content

Clinical Trials Using Tarlatamab

Review the clinical trials studying tarlatamab on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-10 of 10

Tarlatamab for the Treatment of DLL3 Positive Metastatic Prostate Cancer and Neuroendocrine Prostate Cancer, The TIDAL Trial
Status: Active
Location: 9 locations
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
Status: Active
Location: 8 locations
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Status: Active
Location: 7 locations
Tarlatamab for the Treatment of DLL3-Expressing Stage III or IV Neuroendocrine Neoplasms and Other Solid Tumors
Status: Active
Location: 5 locations
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Status: Active
Location: 13 locations
Tarlatamab in Combination with Standard of Care Radiation Therapy for the Treatment of Relapsed or Refractory of DLL3-Expressing Small Cell Lung Cancers and other High Grade Neuroendocrine Cancers
Status: Active
Location: 2 locations
Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
A Study of Hospital-at-Home for People Receiving Tarlatamab, MATCHES-Novel Trial
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Status: Active
Location: 2 locations